InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Douglas Earl Martin. Insider active across 2 companies, notably Allogene Therapeutics, Inc.. In total, 7 reports have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €99k. History available since 14 August 2023. The latest transaction was filed on 21 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Douglas Earl Martin is a declarant linked to Allogene Therapeutics, Inc. (XNAS), where he is SVP, General Counsel. He has 6 filings in total, and among the sampled recent filings, the period runs from 2023-08-17 to 2026-02-04, with EUR 0 of buys and EUR 44700 of sells; the stated transaction nature is Attribution.